Language
Hengrui Pharmaceuticals Is Said to Weigh Second Listing in Hong Kong - Bloomberg

Blog

HomeHome / Blog / Hengrui Pharmaceuticals Is Said to Weigh Second Listing in Hong Kong - Bloomberg
search

Jun 26, 2023

Cuyuna Rock Club agate and mineral show set May 13

Jun 24, 2023

FREMONT ANNOUNCES: Signs Agreement on Vardenis Property in Armenia; Acquires Historic Data from Dundee Precious Metals; Applies for Exploration License over Urasar Mineral District in Northern Armenia

Aug 02, 2023

Neem leaf powder (Azadirachta indica) mitigates oxidative stress and pathological alterations triggered by lead toxicity in Nile tilapia (Oreochromis niloticus)

Oct 09, 2023

Ginkgo Bioworks and Centrient Pharmaceuticals Announce Expansion of Partnership Following Success of Initial Project to Bring Sustainable Innovation to the Generic API Space

Oct 18, 2023

Univar Solutions Expands Specialty Pharmaceutical and Nutraceutical Ingredient Portfolios with Grace SYLOID® FP Silica for Majority of Europe

Send your inquiry
SUBMIT

Oct 24, 2024

Hengrui Pharmaceuticals Is Said to Weigh Second Listing in Hong Kong - Bloomberg

The headquarters of Jiangsu Hengrui Pharmaceuticals Co. in Jiangsu Province. Jiangsu Hengrui Pharmaceuticals Co. is considering a second listing in Hong Kong that could happen as soon as next year,

The headquarters of Jiangsu Hengrui Pharmaceuticals Co. in Jiangsu Province.

Jiangsu Hengrui Pharmaceuticals Co. is considering a second listing in Hong Kong that could happen as soon as next year, according to people familiar with the situation.

The company is in talks with advisers about the potential share sale, which might raise at least $2 billion, the people said, asking not to be identified as the information is private.